Antidepressants and Pregnancy with Dr. Mark Horowitz and Dr. Adam Urato | Webinar

Join Dr. Mark Horowitz, lead author of the Maudsley Deprescribing Guidelines and co-founder of Outro Health, in conversation with Dr. Adam Urato, a Maternal-Fetal Medicine specialist who spoke at the FDA's first panel on SSRIs and pregnancy. This interactive Q&A addresses making medication decisions safer and more transparent for pregnancy planning, conception, and women's health. In this recorded session, Dr. Horowitz and Dr. Urato discuss common questions women have about antidepressants when planning pregnancy, what the science reveals about medication exposure and withdrawal during the perinatal period, and approaches to tapering that prioritize safety for both parent and baby. They explore the importance of informed consent, shared decision-making, and patient-centered care, offering practical guidance on how clinicians and patients can collaborate to balance mental health and pregnancy goals. Whether you're currently taking medication, considering tapering, supporting someone through these decisions, or working as a clinician or caregiver, this session provides evidence-based insights on navigating psychiatric medication use during pregnancy. Dr. Urato brings expertise in high-risk pregnancy care and medication exposures, while Dr. Horowitz shares research on medication withdrawal and long-term use that is transforming clinical practice. Learn more about safe, personalized antidepressant tapering at outro.com Follow @OutroHealth on X, Instagram, TikTok, and LinkedIn for evidence-based content on antidepressant withdrawal and deprescribing. --- SPEAKERS Dr. Mark Horowitz, MBBS, PhD Clinical Research Fellow in Psychiatry (NHS), Visiting Lecturer at King's College London, and Co-Founder of Outro Health. Lead author of the Maudsley Deprescribing Guidelines and co-author of the Royal College of Psychiatrists' guidelines on stopping antidepressants. Dr. Adam Urato Maternal-Fetal Medicine physician based in Framingham, Massachusetts. Harvard College and Harvard Medical School graduate with clinical practice in high-risk pregnancies. Speaker at FDA panel on SSRIs and pregnancy, advocate for informed consent and evidence-based care. --- ABOUT OUTRO Outro is a virtual care platform specializing in safe, personalized antidepressant tapering. Our clinicians use hyperbolic tapering, a neuroscience-backed approach, to help patients discontinue psychiatric medications with greater attention to withdrawal symptoms and safety. Website: outro.com Social: @OutroHealth (X, Instagram, TikTok, LinkedIn) --- #AntidepressantWithdrawal #Pregnancy #MaternalHealth #InformedConsent #Deprescribing #PsychiatricMedication #WomensHealth #OutroHealth